HALOZYME REPORTS SECOND QUARTER 2022 FINANCIAL AND OPERATING RESULTS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. SPY
3. ALAR
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SKA-B
10. PBA

Go back to HALOZYME REPORTS SECOND QUARTER 2022 FINANCIAL AND OPERATING RESULTS

Halozyme Therapeutics (HALO) Tops Q2 EPS by 6c, Offers Guidance

August 9, 2022 5:04 PM EDT

Halozyme Therapeutics (NASDAQ: HALO) reported Q2 EPS of $0.53, $0.06 better than the analyst estimate of $0.47. Revenue for the quarter came in at $152.4 million versus the consensus estimate of $138.63 million.

GUIDANCE:

Halozyme Therapeutics sees FY2022 EPS of $2.10-$2.25, versus the consensus of $2.23.... More